Fluconazole Prophylaxis of Thrush in AIDS

Completed · Phase 4

Conditions studied: Acquired Immunodeficiency Syndrome, Candidiasis, Oral Candidiasis

In brief

This is a placebo-controlled trial of intermittent fluconazole prophylaxis (200 mg orally three times a week) in the prevention of thrush.

Key facts

Study ID

NCT00001542

Run by

National Institute of Allergy and Infectious Diseases (NIAID)

People needed

80

Starts

1996-07-01

Expected to finish

2001-11-01

Last updated by the study team

2008-03-04

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

• National Institute of Allergy and Infectious Diseases (NIAID) — Bethesda, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.